The END7 Campaign is dedicated to building awareness of diseases that infect more than one billion people worldwide

WASHINGTON, DC —January 10, 2012 – Launched today, the END7 campaign is dedicated to eliminating seven major neglected tropical diseases (NTDs) as a public health threat to poor communities by the end of 2020.

NTDs infect one in six people worldwide, including 500 million children, and carry a higher health burden than malaria and tuberculosis.

The effects of these diseases are devastating. NTDs cause blindness, massive swelling in appendages and limbs, severe malnutrition and anemia. They are a leading cause of pregnancy complications among women and are a key source of poverty by reducing school attendance among children and worker productivity for adults.

Treatment for NTDs is one of the most cost-effective health programs available today. Pills to treat the seven leading NTDs are donated by pharmaceutical companies and many programs use existing infrastructure, such as schools and community centers, to administer the treatments.

The END7 campaign raises the public awareness and funding required to cover the costs of distributing medicine and setting up treatment programs in impoverished communities. The annual cost works out to approximately 50 cents to treat and protect one person for a whole year against all seven diseases.

“I’m shocked by how much devastation these diseases cause. But what shocks me more is how simple the solution is. Pocket change to provide medicine that can help end not just one disease, but seven," said actor and campaign sponsor Bill Nighy, who lends his voice to the campaign’s creative animated video.

The first comprehensive campaign to raise public awareness of all seven major NTDs, END7 is run by the Global Network for Neglected Tropical Diseases, an initiative of the Sabin Vaccine Institute. “Unlike many global health campaigns, END7 has an end in sight,” said Dr. Neeraj Mistry, Managing Director of the Global Network. “With enough support and donations we believe we can end the plight of people suffering from these diseases by the end of this decade.”

END7 is a public/private partnership that seeks to catalyze grassroots support for NTD control efforts to encourage major political and philanthropic leaders to increase funding for this important global health issue. The U.S. and UK governments, as well as major pharmaceutical companies, have already made significant contributions. END7 works with global partners such as the World Health Organization and the Bill & Melinda Gates Foundation.

The campaign will be managed through a Facebook hub developed by Wunderman UK to promote campaign videos, photographs, success stories and other content —including a real-time donation ticker. Wunderman’s animated video, ‘Our Mission in a Minute’, describes END7’s goals in an engaging way and is the current featured content on Facebook.

“This campaign is truly about how together, we can have a huge influence on eliminating NTDs as a public health threat in a very short time frame,” said David Harris, Executive Creative Director at Wunderman UK. “By making social media the core of END7, millions of people connected by Facebook and Twitter have an amazing opportunity to help millions of others suffering from these diseases.”

To get involved in the END7 campaign, please visit END7 on Facebook. Together we can see the end!

About NTDs
NTDs are a group of 17 parasitic and bacterial infections that are the most common afflictions of the world's poorest people. The Global Network for Neglected Tropical Diseases focuses on the seven most common NTDs that account for 90 percent of the disease burden--elephantiasis, river blindness, snail fever, trachoma, hookworm, whipworm and roundworm. They blind, disable and disfigure their victims, trapping them in a cycle of poverty and disease. Research shows that treating NTDs lifts millions out of poverty by ensuring that children stay in school to learn and prosper; by strengthening worker productivity; and by improving maternal and child health.

About Sabin Vaccine Institute
Sabin Vaccine Institute is a non-profit, 501(c)(3) organization of scientists, researchers, and advocates dedicated to reducing needless human suffering caused by vaccine preventable and neglected tropical diseases. Sabin works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the world's most pervasive health challenges. Since its founding in 1993 in honor of the oral polio vaccine developer, Dr. Albert B. Sabin, the Institute has been at the forefront of efforts to control, treat, and eliminate these diseases by developing new vaccines, advocating the use of existing vaccines, and promoting increased access to affordable medical treatments. For more information please visit www.sabin.org.

About Wunderman UK
Wunderman is the first name in response-driven marketing that delivers measureable results. With 50+ years of innovation, creativity and analytics, Wunderman transforms businesses—delivering digital, data and creative solutions through its network of 145+ offices in 55+ countries and 19 companies specialising in social, mobile, local and performance marketing. Wunderman stands as the first name in advertising that delivers customer conversations that build brands and generate sales.

Media Contact